3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Carboplatin
69
Paclitaxel
63
Cisplatin
32
Topotecan
29
Gemcitabine
21
Docetaxel
20
Cyclophosphamide
18
Filgrastim
17
liposomal doxorubicin
15
Peripheral Blood Stem Cell Transplantation
15
Bevacizumab
14
sargramostim
11
Taxes
10
Drug Therapy
10
Therapeutics
7
Psychiatric Rehabilitation
7
Immunohistochemistry
7
Erlotinib Hydrochloride
7
Amifostine
7
Melphalan
6
Chemotherapy, Adjuvant
6
rucaparib
5
pembrolizumab
5
mirvetuximab soravtansine
5
ixabepilone
5
Surgical Procedures, Operative
5
Mass Spectrometry
5
Interleukin-12 Subunit p35
5
Flow Cytometry
5
Etoposide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Ovarian Epithelial
×
NUC-1031
×
Clear all
NCT02303912
2021-05-18
ProGem2
Imperial College Healthcare NHS Trust
Phase 1
Completed
25 enrolled